(Note: Candela Medical withdrew its IPO plans in an SEC document dated Sept. 2, 2022. Previously: Candela Medical postponed its IPO “due to market conditions” on Oct. 27, 2021, hours ahead of when the IPO was scheduled for pricing.) 

We are a leading provider of advanced medical device solutions for a broad range of aesthetic applications. Our brands and products have been recognized for their innovation and as leaders in the high growth medical aesthetics space for almost 40 years. We provide energy-based solutions for primarily elective cash-pay procedures that utilize our leading technologies in laser, pulsed light, RF and microneedling. Our brand promise of “Science. Results. Trust.” guides our commitment to patients who can expect efficacious and clinically proven results when receiving a procedure involving a Candela device.

We seek to be the partner of choice for aesthetic practitioners by bringing the best technology solutions to their practices. Through our category-leading products, innovative treatments, robust clinical evidence, extensive post-sale support, and other value drivers, we facilitate practice growth and a quick return on their investment.

(Candela Medical withdrew its IPO plans in an SEC document dated Sept. 2, 2022. Previously: Candela Medical postponed its IPO “due to market conditions” on Oct. 27, 2021, hours ahead of when the IPO was scheduled for pricing.)